Taiwan Liposome Company Ltd Asset Turnover Ratio (TLC), as of fourth quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Taiwan Liposome Company Ltd   (NASDAQ: TLC)
 

Taiwan Liposome Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Taiwan Liposome Ltd 's asset turnover ratio, the ratio that measures the ability of Taiwan Liposome Ltd 's assets to generate revenue, sequentially decreased to 0.06 in the fourth quarter (Dec 31 2020), which does not come as a surprise, as the Taiwan Liposome Ltd continue to experience difficult business climate.

Within sector 209 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2020 compared to the preceding quarter from 3196 to 3740.

Asset Turnover Ratio Definition



TLC Asset Turnover Ratio (Dec 31 2020)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Asset Change 29.5 % 34.45 % 34.45 % 34.45 % -0.47 %
Y / Y Revenue Change -48.08 % - - - 243.42 %
Asset Turnover Ratio (TTM) 0.06 - - - 0.15
TLC's Total Ranking # 3740 # 3196 # 3724 # 0 # 3967
Seq. Asset Change -7.14 % 0 % 0 % 39.45 % -3.58 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 210
Healthcare Sector # 527
Overall Market # 3740

Asset Turnover Ratio Statistics
High Average Low
1.56 1.04 0.75
(Dec 31 2019)   (Dec 31 2020)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Assets at quarter ending Dec 31 2020
Global Blood Therapeutics Inc.  0.17 $ 123.803  Millions$ 719.520  Millions
Lifeward ltd   0.17 $ 4.393  Millions$ 25.556  Millions
Pulmonx Corporation  0.17 $ 32.733  Millions$ 190.950  Millions
Cidara Therapeutics Inc   0.17 $ 12.067  Millions$ 70.398  Millions
Soligenix inc   0.17 $ 2.359  Millions$ 13.812  Millions
Vyne Therapeutics Inc   0.17 $ 20.993  Millions$ 123.200  Millions
Inspiremd Inc   0.17 $ 2.485  Millions$ 14.628  Millions
Addex Therapeutics Ltd  0.17 $ 3.852  Millions$ 22.828  Millions
Fortress Biotech Inc   0.16 $ 45.599  Millions$ 281.656  Millions
Korro Bio Inc   0.16 $ 36.984  Millions$ 229.887  Millions
Exicure Inc   0.16 $ 16.613  Millions$ 103.343  Millions
Rapid Therapeutic Science Laboratories Inc   0.16 $ 0.131  Millions$ 0.820  Millions
Alnylam Pharmaceuticals Inc   0.16 $ 492.853  Millions$ 3,092.084  Millions
New Frontier Health Corp  0.16 $ 327.645  Millions$ 2,056.022  Millions
Sunshine Biopharma Inc   0.16 $ 0.071  Millions$ 0.450  Millions
Pliant Therapeutics Inc   0.16 $ 41.817  Millions$ 263.929  Millions
Editas Medicine Inc   0.16 $ 90.732  Millions$ 572.994  Millions
Cyclo Therapeutics Inc   0.16 $ 0.903  Millions$ 5.717  Millions
Xenon Pharmaceuticals Inc   0.15 $ 32.166  Millions$ 209.008  Millions
Regenerx Biopharmaceuticals inc   0.15 $ 0.077  Millions$ 0.499  Millions
Sutro Biopharma Inc   0.15 $ 42.722  Millions$ 283.190  Millions
Affimed N v   0.15 $ 32.360  Millions$ 214.912  Millions
Remedent Inc   0.15 $ 1.129  Millions$ 7.502  Millions
Cytokinetics Incorporated  0.15 $ 55.828  Millions$ 374.248  Millions
Sol gel Technologies Ltd   0.15 $ 8.771  Millions$ 59.161  Millions
Ligand Pharmaceuticals Incorporated  0.15 $ 186.419  Millions$ 1,259.647  Millions
Arrowhead Pharmaceuticals Inc   0.15 $ 79.840  Millions$ 540.453  Millions
Guardion Health Sciences Inc   0.15 $ 1.890  Millions$ 12.834  Millions
Seres Therapeutics Inc   0.15 $ 33.215  Millions$ 227.610  Millions
Navidea Biopharmaceuticals Inc   0.14 $ 0.915  Millions$ 6.334  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.